Lv5
1440 积分 2024-11-08 加入
Engineering and immobilization of imine reductase enable chemoenzymatic synthesis of SLC6A19 inhibitor JNT-517
2个月前
已完结
First‐in‐human study with ACT‐1014‐6470, a novel oral complement factor 5a receptor 1 (C5aR1) antagonist, supported by pharmacokinetic predictions from animals to patients
2个月前
已完结
Discovery and Characterization of a New Class of C5aR1 Antagonists Showing In Vivo Activity
2个月前
已完结
Synthetic Approaches to the New Drugs Approved During 2021
3个月前
已完结
Cyclic Peptide C5aR1 Antagonist Design Using Solution Conformational Analysis Derived from Residual Dipolar Couplings
3个月前
已完结
Avacopan: First Approval
3个月前
已完结
Glioma
3个月前
已完结
Revisiting an old therapy for new, promising combinations: biology and perspectives of lomustine in glioma treatment
3个月前
已关闭
Temozolomide-Derived Therapeutic Strategies to Overcome Resistance in Glioblastoma
3个月前
已完结
Inhibition mechanism of MRTX1133 on KRASG12D: a molecular dynamics simulation and Markov state model study
3个月前
已完结
皖公网安备34019202002308
